ZWS insider files Form 144 to sell 20,349 shares on NYSE
Rhea-AI Filing Summary
Zurn Elkay Water Solutions (ZWS) filed a Form 144 reporting a proposed sale of 20,349 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $944,934.30. The filing shows the shares were initially granted as restricted stock: 14,788 acquired 12/29/2021 and 5,561 acquired 05/13/2022. The filer also reported a sale on 07/31/2025 of 22,138 shares for gross proceeds of $953,060.82. The filing states that the person represents they have no undisclosed material nonpublic information. Outstanding common shares noted in the form total 167,552,517, and the proposed sale date is 08/27/2025.
Positive
- Timely disclosure of a proposed insider sale including exact share counts, acquisition dates, and aggregate value.
- Transaction transparency: filing identifies broker (Morgan Stanley Smith Barney) and exchange (NYSE) and includes prior recent sale details.
Negative
- Insider selling activity occurred recently (22,138 shares sold on 07/31/2025) and another sale is proposed (08/27/2025), which may merit monitoring by investors.
Insights
TL;DR: Routine insider sale disclosure; size is small relative to float and likely neutral for valuation.
The Form 144 documents a proposed sale of 20,349 shares valued at about $945k and a prior sale of 22,138 shares in July 2025. Compared with the reported outstanding share count of 167.6 million, the proposed sale represents roughly 0.012% of shares outstanding, indicating limited direct market impact. The securities were granted as restricted stock in 2021 and 2022, suggesting this is an executive or employee liquidity event rather than a corporate financing. The filing complies with Rule 144 disclosure requirements and the signer affirms no material nonpublic information.
TL;DR: Disclosure is consistent with governance best practices; repeated sales warrant monitoring but are not material alone.
The report shows timely disclosure of an intended sale and documents the acquisition dates and form of issuance (restricted stock). From a governance perspective, the signer’s attestation of no undisclosed material information is standard and important. The presence of a prior July sale followed by a proposed August sale may reflect a planned selling pattern or liquidity needs under trading plans; the filing itself does not state a 10b5-1 plan. No indications of irregularities are present in the document provided.
FAQ
What does ZWS Form 144 report?
Who is the seller named in the filing for ZWS?
How many shares did the filer acquire and when?
Has the filer sold ZWS shares recently?
What portion of ZWS outstanding shares does the proposed sale represent?